NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Promoters Dispose of 1.5% Stake in Alkem Laboratories

On June 2, promoters of Alkem Laboratories offloaded 1.5 percent shares worth Rs 930 crore to domestic and global investors through open market transactions. As a result, the company's shares may have reacted to the deal, falling 1.42 percent to Rs 5,239 on the National Stock Exchange, extending the downtrend for another session.

The transaction involved Jayanti Sinha, a member of the promoter group, exiting Alkem Laboratories by selling her entire 1.04 percent shareholding (12.38 lakh shares) for Rs 643.87 crore, while Samprada & Nanhamati Singh Family Trust sold 5.5 lakh shares for Rs 286 crore. The transaction price was Rs 5,200 per share. Interestingly, Sarandhar Singh, on behalf of Samprada & Nanhamati Singh Family Trust, holds a significant 18.75 percent stake in Alkem Laboratories.

On the other hand, the 1.5 percent stake sold by promoters was acquired by nine domestic and global investors, including ICICI Prudential Mutual Fund and HDFC Mutual Fund, which were the largest buyers among them. ICICI Prudential Mutual Fund picked up 9.03 lakh shares for Rs 469.83 crore, while HDFC Mutual Fund acquired 5.09 lakh shares for Rs 265 crore. Other notable buyers included DSP Mutual Fund, which purchased 86,538 equity shares of Alkem for Rs 45 crore, and BNP Paribas Arbitrage, Societe Generale, Nippon India Mutual Fund, Morgan Stanley Asia Singapore, Goldman Sachs Bank Europe, and Edelweiss Mutual Fund, each of which acquired 48,090 shares for Rs 25 crore.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

InvestorShares AcquiredAmount (Rs crore)
ICICI Prudential Mutual Fund9.03 lakh469.83
HDFC Mutual Fund5.09 lakh265
DSP Mutual Fund86,53845
BNP Paribas Arbitrage48,09025
Societe Generale48,09025
Nippon India Mutual Fund48,09025
Morgan Stanley Asia Singapore48,09025
Goldman Sachs Bank Europe48,09025
Edelweiss Mutual Fund48,09025

Meanwhile, Axis Mutual Fund sold 2.66 lakh shares in Neogen Chemicals for Rs 47.56 crore at Rs 1,788.01 per share. However, the stock rallied 3.71 percent to Rs 1,876.9 on the National Stock Exchange. Notably, Axis Mutual Fund Trustee, through Axis Small Cap Fund, already held a 5.59 percent stake in Neogen as of April 18, 2026.

Investor Takeaway

Alkem Laboratories' share price may be affected by the significant stake sale to domestic and international investors.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.